13F filing recap · Q3 2009

What did Cantillon Capital Management buy in Q3 2009?

Reported stock-position changes between this filing and the previous one.

Stock value

$428.13M

Positions

Estimated turnover

105.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ORCLOracle Corporation$22.35Mreported value+1.07M shares MONMonsanto Company$19.75Mreported value+255.2K shares BBDBank Bradesco$19.42Mreported value+976.2K shares KMBKimberly-Clark Corporation$16.01Mreported value+271.4K shares

Increased positions

ACNAccenture Plc$41.26Mreported value+624.5K shares+129.4%PMPhilip Morris International Inc.$30.59Mreported value+155.5K shares+32.9%ULUnilever Plc$6.20Mreported value+64.0K shares+42.1%

Reduced positions

WSHWillis Group Holdings Plc$52.44Mreported value-910.5K shares-32.9%COVCovidien Plc$49.45Mreported value-1.11M shares-49.2%BDXBecton Dickinson & Co$45.80Mreported value-966.9K shares-59.6%PFEPfizer Inc.$31.47Mreported value-1.36M shares

Exited positions

PGProcter & Gamble Co$97.33Mprior reported value-1.90M shares-100.0%PDCOPatterson Companies Inc$23.27Mprior reported value-1.07M shares-100.0%AINVApollo Investment Corporation$16.56Mprior reported value-2.76M shares-100.0%IFFInternational Flavors & Fragrances Inc$9.27Mprior reported value